High Levels of Carcinogen Benzene Found in Popular Acne Treatments

Independent lab Valisure's findings prompt FDA petition for recalls, raising concerns over product safety.

Valisure, an independent laboratory, found high levels of benzene, a known carcinogen, in popular acne treatments containing benzoyl peroxide from brands like Proactiv, Clearasil, Clinique, and others.
The FDA has been petitioned by Valisure to recall the affected products and revise industry guidance due to the potential health risks posed by benzene exposure.
Benzene formation in these products is attributed to the decomposition of benzoyl peroxide, especially under high temperatures, posing risks of both contact and inhalation exposure.
Some manufacturers, including Reckitt (Clearasil's parent company) and Estée Lauder (Clinique's parent), have responded by asserting the safety of their products when used as directed.
This discovery follows previous findings of benzene in other consumer products like sunscreens, hand sanitizers, and dry shampoos, leading to recalls and increased scrutiny on product safety.